Olivia Brayer
Stock Analyst at Cantor Fitzgerald
(0)
# 2416
Out of 3,975 analysts
97
Total ratings
37.74%
Success rate
4.55%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Biomarin Pharmaceuti... | Reiterates: Overweight | 90 90 | 66.74 | 34.85% | 14 | Dec 12, 2024 | |
Gilead Sciences | Reiterates: Neutral | 80 80 | 91.4 | -12.47% | 10 | Dec 11, 2024 | |
Omeros | Reiterates: Neutral | n/a | n/a | n/a | 1 | Nov 14, 2024 | |
Vertex Pharmaceutica... | Reiterates: Overweight | 480 480 | 407.36 | 17.83% | 19 | Nov 5, 2024 | |
Regeneron Pharmaceut... | Reiterates: Neutral | 1015 1015 | 718.61 | 41.24% | 8 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 260.75 | 55.32% | 2 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 50 50 | 56.55 | -11.58% | 8 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 220 220 | 234.38 | -6.14% | 23 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 8.58 | 16.55% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 7 | 6.49 | 0.15% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 72 | 41.29 | 74.38% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 21 | n/a | n/a | 2 | Feb 23, 2023 |